Breakthrough Research

Research at Prommune has resulted in an ability to reawaken the body’s own natural immune defenses via the use of novel host-derived immune stimulatory peptides.  Prommune’s lead candidate, a 10-amino acid residue peptide known as EP67, accomplishes this immune activation by its ability to activate a crucial population of immune cells known as antigen presenting cells (monocytes, macrophages, and dendritic cells) and can do so with no effect on inflammatory cells.  Thus, EP67 can be used to invoke the body’s own inherent immune defenses for treating troublesome bacterial, viral, and fungal infections.  Also, EP67 also can easily be incorporated as an immune enhancive component in the generation of a huge variety of vaccines or can be used to enhance the effectiveness of vaccines currently being used.

Prommune, Inc. © 2017